Viral hepatitis
131 results
72 - 131
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review- Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia
Vaccinations - Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease
- Interferon for interferon naive patients with chronic hepatitis C: Cochrane systematic review
- Labour and delivery
- Pharmacological interventions for acute hepatitis B infection
- Entecavir for children and adults with chronic hepatitis B
- Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus
- Pharmacological interventions for acute hepatitis C infection
- Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review
- Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease)
- Prolonged fever in the adult
- Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review
- Hepatic late adverse effects after antineoplastic treatment for childhood cancer
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Interferon alpha for chronic hepatitis D
- Exanthem (eruptive skin rash)
- A patient with jaundice (icterus)
Boceprevir improves SVR in genotype 1 HCV (SPRINT-2)- Assessing a patient with an abnormal liver function test result
- Gloves, extra gloves or special types of gloves for preventing percutaneous exposure injuries in healthcare personnel: Cochrane systematic review
- Viral diseases in warm climates
- Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C
- Updated ACR guideline on managing patients with rheumatoid arthritis
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
- Acute diarrhoeal disease in a traveller
- Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography‐based techniques in adults with chronic liver disease
- Aminoadamantanes for chronic hepatitis C: Cochrane systematic review
- Antioxidant supplements for liver diseases: Cochrane systematic review
- Acute abdomen in the adult
- Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV: Cochrane systematic review
- Pruritus
- Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow‐responder adult patients
- Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis
- Chronic lymphocytic leukaemia (CLL)
- Susceptibility to infections in adults
- Improving vaccination uptake among adolescents
- Granulocyte colony‐stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease
- High-dose furosemide plus small-volume hypertonic saline effective for refractory ascites
- Glomerulonephrites
- Unintentional weight loss in adults
- Extra gloves for preventing percutaneous exposure injuries in healthcare personnel
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Antenatal clinics: care and examinations
- N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
- Renal disease in children (nephrotic and nephritic syndrome)
- Effect of Human Papillomavirus 16/18 L1 virus like particle vaccine among women with pre-existing infection
- Mental disorders due to somatic disease
- Postinfectious syndromes
- Psychosocial interventions for stimulant use disorder